Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1976-03-22
1978-08-08
Helfin, Bernard
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260448R, 2605011, 260518R, 424316, 424317, 560 43, A61K 31245, C07C10160, C07C10162
Patent
active
041057910
ABSTRACT:
The present invention relates to novel monocyclic and polycyclic p-cycloalkylaminobenzoic acids, the corresponding pharmaceutically-acceptable salts and the esters thereof. This invention also relates to methods for reducing plasma lipid levels, especially cholesterol and triglyceride levels, using the compounds of the present invention.
REFERENCES:
patent: 3868416 (1975-02-01), Albright et al.
patent: 3907879 (1975-11-01), Murakami et al.
Matthews Donald P.
Wagner Eugene R.
Ambrosius James W.
Breitenstein G. T.
Helfin Bernard
The Dow Chemical Company
LandOfFree
Hypolipidemic cycloalkylaminobenzoic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hypolipidemic cycloalkylaminobenzoic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypolipidemic cycloalkylaminobenzoic acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-919717